| Genomic heterogeneity of multiple synchronous lung cancer Y Liu, J Zhang, L Li, G Yin, J Zhang, S Zheng, H Cheung, N Wu, N Lu, ... Nature communications 7 (1), 13200, 2016 | 168 | 2016 |
| PAX3-FOXO1 coordinates enhancer architecture, eRNA transcription, and RNA polymerase pause release at select gene targets S Zhang, J Wang, Q Liu, WH McDonald, ML Bomber, HM Layden, J Ellis, ... Molecular cell 82 (23), 4428-4442. e7, 2022 | 18 | 2022 |
| BET inhibition enhances the antileukemic activity of low-dose venetoclax in acute myeloid leukemia HE Ramsey, D Greenwood, S Zhang, M Childress, MP Arrate, AE Gorska, ... Clinical Cancer Research 27 (2), 598-607, 2021 | 18 | 2021 |
| BET inhibitors reduce cell size and induce reversible cell cycle arrest in AML S Zhang, Y Zhao, TM Heaster, MA Fischer, KR Stengel, X Zhou, ... Journal of cellular biochemistry 120 (5), 7309-7322, 2019 | 18 | 2019 |
| Abnormally localized DLK1 interacts with NCOR1 in non-small cell lung cancer cell nuclear J Tan, S Zhang, L Li, J Mu, Z Wang, L Zhang, M Jiang, W Li, X Yang, Y Liu, ... Bioscience Reports 39 (12), BSR20192362, 2019 | 9 | 2019 |
| Up-regulation of DLK1 in non-small cell lung cancer and the relevant molecular mechanism SS Zhang, JJ Tan, L Li, WT Chen, NJ Han, SP Guo, S Zheng, Y Liu, ... Zhonghua Zhong liu za zhi [Chinese Journal of Oncology] 38 (7), 510-514, 2016 | 3 | 2016 |
| The BET Inhibitor INCB054329 Primes AML Cells for Venetoclax-Induced Apoptosis H Ramsey, S Zhang, Y Zhao, MA Fischer, AE Gorska, M Arrate, L Fuller, ... Blood 132, 4074, 2018 | | 2018 |
Melissa C. SkalaProf. of Biomedical Engineering, University of Wisconsin - Madison; Morgridge Institute for Research在 wisc.edu 的电子邮件经过验证
